(1R,5R,8S,11R)-3,3,7,11-tetramethyl-12-oxatricyclo[6.3.1.01,5]dodec-6-ene-5,8-diol

Details

Top
Internal ID b3ad4f5b-7cee-4243-b879-fc9daf5a22c8
Taxonomy Organoheterocyclic compounds > Pyrans
IUPAC Name (1R,5R,8S,11R)-3,3,7,11-tetramethyl-12-oxatricyclo[6.3.1.01,5]dodec-6-ene-5,8-diol
SMILES (Canonical) CC1CCC2(C(=CC3(C1(O2)CC(C3)(C)C)O)C)O
SMILES (Isomeric) C[C@@H]1CC[C@]2(C(=C[C@]3([C@@]1(O2)CC(C3)(C)C)O)C)O
InChI InChI=1S/C15H24O3/c1-10-5-6-15(17)11(2)7-13(16)8-12(3,4)9-14(10,13)18-15/h7,10,16-17H,5-6,8-9H2,1-4H3/t10-,13+,14-,15+/m1/s1
InChI Key YCTDLGNLUVIXEV-KAOXEZKKSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C15H24O3
Molecular Weight 252.35 g/mol
Exact Mass 252.17254462 g/mol
Topological Polar Surface Area (TPSA) 49.70 Ų
XlogP 1.50
Atomic LogP (AlogP) 2.37
H-Bond Acceptor 3
H-Bond Donor 2
Rotatable Bonds 0

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (1R,5R,8S,11R)-3,3,7,11-tetramethyl-12-oxatricyclo[6.3.1.01,5]dodec-6-ene-5,8-diol

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9851 98.51%
Caco-2 + 0.8585 85.85%
Blood Brain Barrier - 0.5500 55.00%
Human oral bioavailability + 0.6000 60.00%
Subcellular localzation Mitochondria 0.6840 68.40%
OATP2B1 inhibitior - 0.8506 85.06%
OATP1B1 inhibitior + 0.9348 93.48%
OATP1B3 inhibitior + 0.9251 92.51%
MATE1 inhibitior - 0.9400 94.00%
OCT2 inhibitior - 0.7250 72.50%
BSEP inhibitior - 0.8168 81.68%
P-glycoprotein inhibitior - 0.9565 95.65%
P-glycoprotein substrate - 0.8934 89.34%
CYP3A4 substrate + 0.5280 52.80%
CYP2C9 substrate + 0.5892 58.92%
CYP2D6 substrate - 0.8093 80.93%
CYP3A4 inhibition - 0.8403 84.03%
CYP2C9 inhibition - 0.9057 90.57%
CYP2C19 inhibition - 0.8185 81.85%
CYP2D6 inhibition - 0.9338 93.38%
CYP1A2 inhibition - 0.8130 81.30%
CYP2C8 inhibition - 0.8251 82.51%
CYP inhibitory promiscuity - 0.8734 87.34%
UGT catelyzed + 0.6000 60.00%
Carcinogenicity (binary) - 0.9600 96.00%
Carcinogenicity (trinary) Non-required 0.6177 61.77%
Eye corrosion - 0.9931 99.31%
Eye irritation - 0.5201 52.01%
Skin irritation + 0.5514 55.14%
Skin corrosion - 0.9297 92.97%
Ames mutagenesis - 0.6840 68.40%
Human Ether-a-go-go-Related Gene inhibition - 0.4910 49.10%
Micronuclear - 0.8600 86.00%
Hepatotoxicity - 0.5196 51.96%
skin sensitisation - 0.6536 65.36%
Respiratory toxicity - 0.5778 57.78%
Reproductive toxicity + 0.9111 91.11%
Mitochondrial toxicity + 0.8875 88.75%
Nephrotoxicity + 0.4673 46.73%
Acute Oral Toxicity (c) III 0.4741 47.41%
Estrogen receptor binding - 0.6416 64.16%
Androgen receptor binding + 0.5665 56.65%
Thyroid receptor binding + 0.5609 56.09%
Glucocorticoid receptor binding - 0.5717 57.17%
Aromatase binding + 0.5418 54.18%
PPAR gamma - 0.7580 75.80%
Honey bee toxicity - 0.9571 95.71%
Biodegradation - 0.6500 65.00%
Crustacea aquatic toxicity + 0.5700 57.00%
Fish aquatic toxicity + 0.9685 96.85%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL253 P34972 Cannabinoid CB2 receptor 91.78% 97.25%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 89.96% 91.11%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 88.71% 96.09%
CHEMBL1994 P08235 Mineralocorticoid receptor 86.33% 100.00%
CHEMBL3137262 O60341 LSD1/CoREST complex 85.47% 97.09%
CHEMBL4803 P29474 Nitric-oxide synthase, endothelial 84.94% 86.00%
CHEMBL241 Q14432 Phosphodiesterase 3A 81.59% 92.94%
CHEMBL5608 Q16288 NT-3 growth factor receptor 81.40% 95.89%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
There are no matching plants.

Cross-Links

Top
PubChem 73352239
LOTUS LTS0209089
wikiData Q105346469